# Brady Corp: Form 10-Q for the period ended Jan 31, 2017

- Company: [Brady Corp](/companies/brc.md) (CIK 746598)
- Form: 10-Q
- Filed: 2017-02-23
- Accepted by EDGAR: Feb 23, 2017, 07:48 ET
- Period: 2017-01-31
- Accession: 0000746598-17-000021
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/746598/000074659817000021/brc-20170131x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/746598/000074659817000021/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-01-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-11-01 to 2017-01-31 | $268.0m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months, 2016-08-01 to 2017-01-31 | $548.2m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2016-11-01 to 2017-01-31 | $133.8m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2016-08-01 to 2017-01-31 | $273.7m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2016-11-01 to 2017-01-31 | $134.2m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2016-08-01 to 2017-01-31 | $274.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2016-11-01 to 2017-01-31 | $9.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2016-08-01 to 2017-01-31 | $18.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2016-11-01 to 2017-01-31 | $94.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2016-08-01 to 2017-01-31 | $192.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2016-11-01 to 2017-01-31 | $30.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2016-08-01 to 2017-01-31 | $63.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2016-11-01 to 2017-01-31 | $1.5m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2016-08-01 to 2017-01-31 | $3.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2016-11-01 to 2017-01-31 | $3.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2016-08-01 to 2017-01-31 | $12.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-11-01 to 2017-01-31 | $25.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2016-08-01 to 2017-01-31 | $47.9m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2016-11-01 to 2017-01-31 | 51,954,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2016-08-01 to 2017-01-31 | 51,721,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2016-08-01 to 2017-01-31 | $53.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2016-08-01 to 2017-01-31 | $7.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2016-08-01 to 2017-01-31 | $20.9m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2016-08-01 to 2017-01-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-01-31 | $125.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-01-31 | $381.7m | us-gaap:AssetsCurrent |
| Total assets | at 2017-01-31 | $1.00bn | us-gaap:Assets |
| Current liabilities | at 2017-01-31 | $150.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-01-31 | $368.2m | us-gaap:Liabilities |
| Long-term debt | at 2017-01-31 | $157.2m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2017-01-31 | $634.9m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/746598/000074659817000021/brc-20170131x10q.htm

Filed Feb 23, 2017.
Source: SEC EDGAR, the filing index for accession 0000746598-17-000021. Last ingested by Listed: Nov 9, 2026, 17:29 ET. No prices; not investment advice.
